OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ALKERMES PLC DL-,01/  IE00B56GVS15  /

Frankfurt
23/05/2024  08:23:56 Chg. 0.0000 Volume Bid10:00:01 Ask10:00:01 Market Capitalization Dividend Y. P/E Ratio
22.0000EUR 0.00% 0
Turnover: 0.0000		 22.0000Bid Size: 100 22.8000Ask Size: 100 3.79 bill.EUR - -
GlobeNewswire 26/03 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Up...
GlobeNewswire 06/03 Zenas BioPharma Appoints Patricia Allen to its Board of Directors
GlobeNewswire 18/01 SediVision Wastewater Technology Announces New Company Vice President
GlobeNewswire 08/01 Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
GlobeNewswire 04/12/2023 Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
GlobeNewswire 15/11/2023 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 26/09/2023 OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
GlobeNewswire 11/09/2023 Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire 29/08/2023 Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer
GlobeNewswire 28/03/2022 Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business...
GlobeNewswire 16/03/2022 Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Newsfile Corp 15/03/2022 Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development
GlobeNewswire 15/03/2022 Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 08/03/2022 Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surg...
GlobeNewswire 02/03/2022 Baudax Bio Announces Seventh Orange Book Listable Patent for ANJESO®
GlobeNewswire 10/02/2022 Finch Therapeutics Announces Additions to Senior Leadership Team
GlobeNewswire 24/01/2022 Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates
GlobeNewswire 06/12/2021 AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
GlobeNewswire 22/11/2021 Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors
GlobeNewswire 04/11/2021 Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 08/09/2021 Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer
GlobeNewswire 05/08/2021 Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights
GlobeNewswire 22/06/2021 BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board
GlobeNewswire 08/06/2021 Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on th...
GlobeNewswire 17/05/2021 Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management